Some hopes and concerns regarding medical event-reporting systems - Lessons from the NASA Aviation Safety Reporting System

被引：0
|
作者：
Billings, CE [1 ]
机构：
[1] Ohio State Univ, Cognit Syst Engn Lab, Columbus, OH 43210 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 1998年 / 122卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：214 / 215
页数：2
相关论文
共 50 条
  • [21] Safety concerns of aztreonam: a real-world disproportionality analysis based on FDA Adverse Event Reporting System
    Cai, Li-li
    Zhou, Hong
    Wu, Na-mei
    Hong, Li-mian
    Lin, Zhi-hang
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (03) : 325 - 344
  • [22] Post-marketing safety concerns with montelukast: A pharmacovigilance study based on the FDA adverse event reporting system
    Ou, Zhimin
    Han, Ying
    Zhuang, Wei
    Xiao, Yunshan
    Cai, Shuying
    Zhang, Xueqin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2024, 62 (11) : 497 - 506
  • [23] Post-marketing safety concerns of sotorasib: A disproportionality analysis based on FDA adverse event reporting system
    Ding, Yiling
    Su, Hongyan
    Shu, Yamin
    Chen, Jing
    HELIYON, 2024, 10 (09)
  • [24] Safety Data on Meningococcal Polysaccharide Vaccine from the Vaccine Adverse Event Reporting System
    Ball, R
    Braun, MM
    Mootrey, GT
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) : 1273 - 1280
  • [25] Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
    Zeng, Yanbin
    Lin, Wanlong
    Zhuang, Wei
    ANDROLOGY, 2024,
  • [26] Post-marketing safety concerns with lecanemab: a pharmacovigilance study based on the FDA Adverse Event Reporting System database
    Xing, Xiaoxuan
    Zhang, Xiaotong
    Wang, Ke
    Wang, Zhizhou
    Feng, Yingnan
    Li, Xiaoxi
    Hua, Yiming
    Zhang, Lan
    Dong, Xianzhe
    ALZHEIMERS RESEARCH & THERAPY, 2025, 17 (01)
  • [27] Alarms, alerts, and warnings in air traffic control: An analysis of reports from the Aviation Safety Reporting System
    Ruskin, Keith J.
    Corvin, Chase
    Rice, Stephen
    Richards, Grace
    Winter, Scott R.
    Ruskin, Anna Clebone
    TRANSPORTATION RESEARCH INTERDISCIPLINARY PERSPECTIVES, 2021, 12
  • [28] Cardiovascular Safety Evaluation of Febuxostat and Allopurinol: Findings from the FDA Adverse Event Reporting System
    Bai, Yang
    Wu, Bin
    Gou, Liangwen
    Fang, Zhenwei
    Xu, Ting
    Zhang, Tiejun
    Li, Yuwen
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [29] Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system
    Zhu, Zhou
    Liu, Mingjuan
    Zhang, Hanlin
    Zheng, Heyi
    Li, Jun
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [30] Post-marketing safety concerns with lumateperone: a pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database
    Zhao, Dan
    Zhang, Wangxin
    Liu, Yan
    Yan, Zhaojun
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345